Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles

被引:137
作者
Dillen, K
Vandervoort, J
Van den Mooter, G
Verheyden, L
Ludwig, A
机构
[1] Univ Instelling Antwerp, Dept Pharmaceut Sci, Lab Pharmaceut Technol & Biopharm, B-2610 Antwerp, Belgium
[2] Katholieke Univ Leuven, O&N, Lab Pharmaceut Technol & Biopharm, B-3000 Louvain, Belgium
关键词
PLGA; nanoparticles; W/O/W emulsification solvent evaporation method; cipofloxacin; experimental design;
D O I
10.1016/j.ijpharm.2004.01.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poly(lactide-co-glycolide) nanoparticles incorporating ciprolloxacin HCl were prepared by means of a W/O/W emulsification solvent evaporation method. The stabiliser selected was poly(vinylalcohol). A 2(4) full factorial design based on four independent variables was used to plan the experiments and the variable parameters were the number of homogenisation cycles, addition of boric acid to the inner water phase containing the drug, ciprofloxacin concentration in the inner water phase and oil:outer water phase ratio. The effects of these parameters on the particle size, zeta potential, drug loading efficiency and drug release were investigated. Also the effect of gamma irradiation on the particle size and drug release was evaluated and DSC and XRD analyses of the compounds and the nanoparticles were performed. The activity on two series of microorganisms, Pseudomonas aeruginosa and Staphylococcus aureus, was examined. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 187
页数:17
相关论文
共 40 条
[1]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[2]   The microbiology of the eye [J].
Armstrong, RA .
OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2000, 20 (06) :429-441
[3]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[4]   In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens [J].
Callegan, MC ;
Booth, MC ;
Gilmore, MS .
CORNEA, 2000, 19 (04) :539-545
[5]   Improved ocular bioavailability of indomethacin by novel ocular drug carriers [J].
Calvo, P ;
Alonso, MJ ;
VilaJato, JL ;
Robinson, JR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (11) :1147-1152
[6]   Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique [J].
Castellanos, IJ ;
Carrasquillo, KG ;
López, JD ;
Alvarez, M ;
Griebenow, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (02) :167-178
[7]   Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics [J].
Chorny, M ;
Fishbein, I ;
Danenberg, HD ;
Golomb, G .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :389-400
[8]   Differential scanning calorimetry: applications in drug development [J].
Clas, SD ;
Dalton, CR ;
Hancock, BC .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (08) :311-320
[9]  
*COUNC EUR, 1997, EUR PHARM, P637
[10]  
COUVREUR P, 1995, EUR J PHARM BIOPHARM, V41, P2